Australia's most trusted
source of pharma news
Posted 28 October 2021 AM
Two health industry heavyweights - CEO of Rare Cancers Australia Richard Vines and former Secretary of the Department of Health Glenys Beauchamp - have been recruited to join Medicines Australia's future-focused Advisory Council ahead of its next meeting in November.
"It is with great pleasure to introduce these two brilliant minds to the Advisory Council," Chair of MA Board and Chair of the Advisory Council, Dr Anna Lavelle said.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.